The rapid advancement of technology across industries has significantly transformed the global healthcare landscape, and the medical technology (MedTech) sector stands at the forefront of this evolution. Once limited primarily to diagnostics, medical devices and digital health solutions are now increasingly being used for preventive care, early intervention, and improved patient outcomes. According to industry estimates, the global MedTech market is projected to reach USD 594 billion by 2024, reflecting the sector’s accelerating growth and innovation.
Europe has emerged as a major contributor to this expansion, positioning itself as the second-largest MedTech market globally after the United States. The continent’s strong emphasis on research, engineering excellence, and regulatory standards has created fertile ground for innovation. With over 14,000 patent applications filed in recent years, Europe continues to demonstrate its leadership in developing next-generation medical technologies.
Speaking on this growth trajectory, Rajat Khare, founder of Luxembourg-based investment firm Boundary Holding, emphasized Europe’s growing influence in shaping the future of MedTech. Boundary Holding has actively supported companies developing breakthrough solutions across healthcare and life sciences, enabling innovators to scale and bring advanced technologies to market.
Across Europe, MedTech startups and scale-ups are addressing a wide range of healthcare challenges. Companies like Neo Medical are developing AI-powered solutions such as Assist AI, which provides real-time guidance to spine surgeons, helping reduce stress overload on patients’ spines during complex procedures. In ophthalmology, Remidio has made significant strides with its handheld, non-mydriatic fundus camera, allowing fast and accurate retinal imaging even in resource-constrained settings. Meanwhile, Scewo has redefined mobility solutions with its motorized wheelchair capable of navigating uneven terrain and climbing stairs, improving independence for people with disabilities.
Khare believes that the future of MedTech lies in the convergence of advanced digital technologies. “The growing digital world will not be limited to any single sector,” he has noted, pointing to the increasing integration of artificial intelligence, cloud computing, augmented and virtual reality, and emerging technologies such as quantum computing within healthcare solutions. These innovations are expected to make medical care more precise, accessible, and efficient.
Industry leaders across Europe echo similar optimism. At Deloitte Switzerland, Michel Le Bars, who oversees mergers and acquisitions in the life sciences and healthcare sectors, has highlighted Switzerland’s strong position in MedTech, citing its high density of manufacturers and specialized suppliers as a key competitive advantage. Likewise, Charity Kufaas, Vice President of Strategy and Commercial Development for EMEA at Medtronic in Switzerland, has emphasized Europe’s strategic importance for collaboration across cardiology, neuroscience, diabetes care, and medical-surgical innovation.
As investment activity continues to rise, financial institutions and venture firms are playing a crucial role in transforming research-driven ideas into real-world healthcare solutions. According to Khare, sustained investor support is essential to ensure that innovation translates into scalable, patient-centric outcomes.
With strong backing from firms like Boundary Holding and growing collaboration between startups, healthcare providers, and global corporations, Europe is poised to play an even greater role in shaping the future of global MedTech investment. The sector’s continued growth signals a future where technology-driven healthcare solutions become more accessible, efficient, and impactful worldwide.
Source of URL- https://theceoviews.com/european-investment-firms-are-playing-a-major-role-by-contributing-more-to-medtech/